Peter C. Black

Active 2000–2026

Also published as
Peter C. BLACK
212
Papers
18,548
Citations
80
h-index
181
i10-index

Citations

Citations per year for Peter C. Black1991: 1 citations1993: 1 citations2001: 1 citations2003: 3 citations2004: 4 citations2005: 3 citations2006: 6 citations2007: 6 citations2008: 8 citations2009: 21 citations2010: 23 citations2011: 17 citations2012: 30 citations2013: 30 citations2014: 59 citations2015: 58 citations2016: 75 citations2017: 91 citations2018: 112 citations2019: 525 citations2020: 803 citations2021: 880 citations2022: 697 citations2023: 630 citations2024: 1,175 citations2025: 622 citations2026: 34 citations1992: no citations, so this year is not shown1994–2000: no citations, so these years are not shown2002: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,765 citing papers, 20.2% of this breakdownChina: 1,095 citing papers, 12.5% of this breakdownCanada: 544 citing papers, 6.2% of this breakdownUnited Kingdom: 491 citing papers, 5.6% of this breakdownItaly: 489 citing papers, 5.6% of this breakdownGermany: 475 citing papers, 5.4% of this breakdownFrance: 353 citing papers, 4.1% of this breakdownNetherlands: 290 citing papers, 3.3% of this breakdownSpain: 278 citing papers, 3.2% of this breakdownJapan: 221 citing papers, 2.5% of this breakdownAustria: 214 citing papers, 2.5% of this breakdownSwitzerland: 199 citing papers, 2.3% of this breakdown
0%20.2%Other 26.6%

Fields

  • Medicine67.1%
  • Biochemistry, Genetics and Molecular Biology17.7%
  • Computer Science6.8%
  • Engineering3.2%
  • Immunology and Microbiology2.2%
  • Health Professions0.7%
  • Other2.3%

Topics

  • Bladder and Urothelial Cancer Treatments13.3%
  • Urinary and Genital Oncology Studies6.6%
  • Prostate Cancer Diagnosis and Treatment4.2%
  • Prostate Cancer Treatment and Research4%
  • Ferroptosis and cancer prognosis3.3%
  • Cancer Immunotherapy and Biomarkers3.1%
  • Other65.5%

Coauthors

All papers

Open in search
  1. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mattias Aine, Hikmat Al-Ahmadie, Yves Allory, Joaquim Bellmunt, Isabelle Bernard-Pierrot, Peter C. Black, Mauro A.A. Castro, Keith Syson Chan, Woonyoung Choi, Bogdan Czerniak, Colin P. Dinney, Lars Dyrskjøt, Pontus Eriksson, Jacqueline Fontugne, Ewan A. Gibb, Clarice S. Groeneveld, Arndt Hartmann, Katherine A. Hoadley, Mattias Höglund, Aurélie Kamoun, Jordan Kardos, Jaegil Kim, William Y. Kim, David J. Kwiatkowski, Thierry Lebrét, Seth P. Lerner, Fredrik Liedberg, Núria Malats, David J. McConkey, Qianxing Mo, Thomas Powles, François Radvanyi, Francisco X. Real, Aurélien de Reyniès, A. Gordon Robertson, Arlene O. Siefker‐Radtke, Nanor Sirab, Roland Seiler, Gottfrid Sjödahl, Ann Taber, John N. Weinstein, Alexandre Zlotta - European Urology 2019 cited by 1,360

  2. Universal DNA methylation age across mammalian tissues

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lisa Chakrabarti, Ioulia Chatzistamou, Hao Chen, Kai Cheng, Priscila Chiavellini, Oi‐Wa Choi, Shannon Clarke, Lisa Noelle Cooper, Marie‐Laurence Cossette, Joanna Day, Joseph DeYoung, Stacy DiRocco, Christopher Dold, Erin E. Ehmke, Candice K. Emmons, Stephan Emmrich, Ebru Erbay, Claire Erlacher‐Reid, Chris G. Faulkes, Steven H. Ferguson, Carrie J. Finno, Jennifer E. Flower, Jean‐Michel Gaillard, Eva Garde, Livia Gerber, Vadim N. Gladyshev, Vera Gorbunova, Rodolfo G. Goya, Myles J.A. Grant, C. B. Green, Erin N. Hales, M. Bradley Hanson, Daniel W. Hart, Martin Haulena, K. Herrick, Andrew N. Hogan, Carolyn J. Hogg, Timothy A. Hore, Taosheng Huang, Juan Carlos Izpisúa Belmonte, Anna J. Jasinska, Gareth Jones, Eve Jourdain, Olga Kashpur, Harold L. Katcher, Etsuko Katsumata, Vimala Kaza, Hippokratis Kiaris, Michael S. Kobor, Paweł Kordowitzki, William R. Koski, Michael Krützen, Soon‐Bae Kwon, Brenda Larison, Sang‐Goo Lee, Marina Lehmann, Jean‐François Lemaître, Arnold J. Levine, Chunquan Li, X. Li, A. R. Lim, David Lin, D. Lindemann, Tom J. Little, Nicholas Macoretta, Debra Maddox, Craig O. Matkin, Julie A. Mattison, Mélanie McClure, June Mergl and 88 more - Nature Aging 2023 cited by 387

  3. Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors

    Authors: , , , , , , , , , , , , , , , , - European Urology 2023 cited by 481

  4. Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018

    Authors: , , , , , , , , , , , - European Urology 2018 cited by 840

  5. Automatic grading of prostate cancer in digitized histopathology images: Learning from multiple experts

    Authors: , , , , , , , , , , , , , , , - Medical Image Analysis, Medical Image Anal. 2018 cited by 177

  6. Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jonathan L. Wright, Marc Dall’Era, Michiel S. van der Heijden, Peter C. Black - European Urology 2017 cited by 792

  7. Urine biomarkers in bladder cancer — current status and future perspectives

    Authors: , , - Nature Reviews Urology 2023 cited by 144

  8. Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

    Authors: , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 cited by 155

  9. Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy

    Authors: , , , , , , , , , , , , , , , , , , - PLoS ONE 2013 cited by 665

  10. Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per Capita

    Authors: , , , , , , , , , , , , - European Urology 2020 cited by 262

  11. Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 159

  12. Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin–unresponsive High-risk Non–muscle-invasive Bladder Cancer: SWOG S1605

    Authors: , , , , , , , , , , , , , , - European Urology 2023 cited by 91

  13. Deep Learning-Based Gleason Grading of Prostate Cancer From Histopathology Images - Role of Multiscale Decision Aggregation and Data Augmentation

    Authors: , , , , , - IEEE Journal of Biomedical and Health Informatics, IEEE J. Biomed. Health Informatics 2019 cited by 150

  14. 100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19

    Authors: , , , , , , , , , , , , , - Nature Reviews Urology 2021 cited by 147

  15. Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective

    Authors: , , , , , - Nature Reviews Urology 2022 cited by 196

  16. Data Sharing Under the General Data Protection Regulation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Goce Spasovski, Jan A. Staessen, Dimitrios Stamatialis, Peter Stenvinkel, Christoph Wanner, Stephen B. Williams, Faı̈ez Zannad, Carmine Zoccali, Raymond Vanholder - Hypertension 2021 cited by 130

  17. Comparison of Multiparametric Magnetic Resonance Imaging–Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2021 cited by 202

  18. Kdm6a Deficiency Activates Inflammatory Pathways, Promotes M2 Macrophage Polarization, and Causes Bladder Cancer in Cooperation with p53 Dysfunction

    Authors: , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 cited by 171

  19. The consensus molecular classification of muscle-invasive bladder cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , The Bladder Cancer Molecular Taxonomy Group - 2018 cited by 152

  20. TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells

    Authors: , , , , , , , , , , , , , , , , , , - European Urology Oncology 2022 cited by 86

  21. Enhanced recovery after surgery (ERAS) protocols: Time to change practice?

    Authors: , , , - Canadian Urological Association Journal 2011 cited by 377

  22. Transcriptional-translational conflict is a barrier to cellular transformation and cancer progression

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2023 cited by 59

  23. Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter C. Black, Enrique Grande, Sanjeev Mariathasan - Cell Reports Medicine 2024 cited by 54

  24. Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials

    Authors: , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2019 cited by 166